Why is Surgical Innovations Group Plc ?
1
With a growth in Net Sales of 6.5%, the company declared Very Positive results in Jun 25
- OPERATING PROFIT(Q) Highest at GBP 0.37 MM
- OPERATING PROFIT MARGIN(Q) Highest at 6.07 %
- PRE-TAX PROFIT(Q) Highest at GBP 0.02 MM
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -18.18%, its profits have fallen by -11%
3
Below par performance in long term as well as near term
- Along with generating -18.18% returns in the last 1 year, the stock has also underperformed FTSE 100 in the last 3 years, 1 year and 3 months
How much should you hold?
- Overall Portfolio exposure to Surgical Innovations Group Plc should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Surgical Innovations Group Plc for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Surgical Innovations Group Plc
-100.0%
0.50
25.02%
FTSE 100
18.88%
2.00
10.96%
Quality key factors
Factor
Value
Sales Growth (5y)
7.72%
EBIT Growth (5y)
13.25%
EBIT to Interest (avg)
-0.67
Debt to EBITDA (avg)
0.10
Net Debt to Equity (avg)
0.06
Sales to Capital Employed (avg)
0.93
Tax Ratio
5.22%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.14%
ROE (avg)
0.54%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.49
EV to EBIT
-5.13
EV to EBITDA
5.13
EV to Capital Employed
0.54
EV to Sales
0.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-4.73%
ROE (Latest)
-4.98%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bullish
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Movement
11What is working for the Company
OPERATING PROFIT(Q)
Highest at GBP 0.37 MM
OPERATING PROFIT MARGIN(Q)
Highest at 6.07 %
PRE-TAX PROFIT(Q)
Highest at GBP 0.02 MM
NET PROFIT(Q)
Highest at GBP 0.02 MM
EPS(Q)
Highest at GBP 0
-3What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 5.41% (YoY
DEBT-EQUITY RATIO
(HY)
Highest at 16.34 %
DEBTORS TURNOVER RATIO(HY)
Lowest at 4.72 times
Here's what is working for Surgical Innovations Group Plc
Pre-Tax Profit
At GBP 0.02 MM has Grown at 111.48%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (GBP MM)
Net Profit
At GBP 0.02 MM has Grown at 111.48%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (GBP MM)
Operating Profit
Highest at GBP 0.37 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (GBP MM)
Operating Profit Margin
Highest at 6.07 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at GBP 0.02 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (GBP MM)
Net Profit
Highest at GBP 0.02 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (GBP MM)
EPS
Highest at GBP 0
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (GBP)
Here's what is not working for Surgical Innovations Group Plc
Debt-Equity Ratio
Highest at 16.34 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio
Lowest at 4.72 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 5.41% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






